Product Liability Lawyer Blog

Bayer, the maker of blood clotting drug, Trasylol, announced that it plans to recall what is left of the allegedly defective medication from the US Markets - this, according to the FDA. In November of 2007, Trasylol was suspended for use in heart surgery by the FDA after a Canadian clinical study showed a heightened risk of death versus too other drugs that are used to manage blood loss during surgery.

Trasylol was previously used by patients who were at a higher risk of blood loss during coronary artery bypass surgery.

If you or a loved one has been injured or killed by Trasylol or any other defective drug, I would invite you to visit my website www.samlevine.com or contact my office, Sam Levine, Attorney at Law.

Posted by Sam Levine | Permalink | Email This Post

Posted In: Defective Drugs , Products Liability , Trasylol

Bookmark:

Following multiple studies and the recall of Trasylol, Bayer, the drug maker, is now facing a multitude of injury and wrongful death claims. The blood thinning medication was expected to be a huge money maker for Bayer, but as complications during and after surgery occurred, including amputation of limbs, kidney failure and death, Bayer under internal and FDA pressure, yanked the medicine.

The unfortunate thing is that there were other blood thinning medications besides Trasylol that could have been used during open heart surgeries that were much cheaper and safer. It is estimated that over 1,000 people per month have died as a direct result of complications brought on by Trasylol.

If you or a loved one has been injured or died as a result of Trasylol, I would encourage you to visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.

Posted by Sam Levine | Permalink | Email This Post

Posted In: Defective Drugs , Products Liability , Trasylol , Wrongful Death

Bookmark: